Probiotics in Health and Disease: Potential for Pets

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 26, Issue SUPPL, 2004, Pages 29-33

  Benyacoub, Jalil ^a   Cavadini, Christoph ^a   Von der Weid, Thierry ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542350809     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Fuller R: Probiotics in man and animals. J Appl Bacterial 66(5):365-378, 1989.
2. Salminen S, von Wright A, Morelli L, et al: Demonstration of safety of probiotics - a review. Int J Food Microbiol 44(1-2):93-106, 1998.
3. Mitsuoka T: The human gastrointestinal tract, in Wood BIB (ed): The Lactic Acid Bacteria. New York, Elsevier Applied Sciences, 1992, pp 69-114.
4. Willard MD, Simpson RB, Cohen ND, Clancy JS: Effects of dietary fructooligosaccharide on selected bacterial populations in feces of dogs. Am J Vet Res 61 (7):820-825, 2000.
5. Zentek J: Bacterial flora of the canine alimentary tract: Physiology, feeding influences and dietary consequences. Kleintierpraxis 45:523-534, 2000.
6. Biourge V, Vallet C, Levesque A, et al: The use of probiotics in the diet of dogs. J Nutr 128(suppl 12):2730S-2732S, 1998.
7. Martineau B: Comparison of four media for the selection of bifidobacteria in dog fecal samples. Anaerobe 5:123-127, 1999.
8. Benyacoub J, Czarnecki-Maulden GL, Cavadini C, et al: Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 133(4):1158-1162, 2003.
9. Cebra JJ: Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69(5):1046S-1051S, 1999.
10. Isolauri E, Sutas Y, Kankaanpaa P, et al: Probiotics: Effects on immunity. Am J Clin Nutr 73(suppl 2):444S-450S, 2001.
11. Tuomola E, Crittenden R, Playne M, et al: Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 73(suppl 2):393S-398S, 2001.
12. Unpublished data, Nestlé Research Center, Lausanne, Switzerland, 2003.
13. Bernet-Camard MF, Lievin V, Brassart D, et al: The human Lactobacillus acidophilus strain LA 1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63(7):2747-2753, 1997.
14. Bernet MF, Brassart D, Neeser JR, Servin AL: Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 59(12):4121-4128, 1993.
15. Bernet MF, Brassart D, Neeser JR, Servin AL: Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35(4):483-489, 1994.
16. Coconnier MH, Lievin V, Bernet-Camard MF, et al: Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41(5): 1046-1052, 1997.
17. Hudault S, Lievin V, Bernet-Camard MF, Servin AL: Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63(2):513-518, 1997.
18. Alander M, De SI, Nollet L, et al: The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). Int J Food Microbiol 46(1):71-79, 1999.
19. Goldin BR: Health benefits of probiotics. Br J Nutr 80(4):S203-S207, 1998.
20. Rolfe RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130(suppl 25):396S-402S, 2000.
21. Coconnier MH, Bernet MF, Kerneis S, et al: Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 110(3):299-305, 1993.
22. Bhatia SJ, Kochar N, Abraham P, et al: Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 27(10):2328-2330, 1989.
23. Barefoot SF, Klaenhammer TR: Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol 45(6):1808-1815, 1983.
24. Talarico TL, Dobrogosz WJ: Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother 33(5):674-679, 1989.
25. Pfeifer A, Rosat JP: Probiotics in alimentation: Clinical evidence for their enhancement of the natural immunity of the gut, in Probiotics, Other Nutritional Factors and Intestinal Microflora, Philadelphia, Lippincott Raven, 2000, pp 243-257.
26. Pelto L, Isolauri E, Lilius EM, et al: Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy 28(12):1474-1479, 1998.
27. Eaton TJ, Gasson MJ: Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 67(4):1628-1635, 2001.
28. Franz CM, Muscholl-Silberhorn AB, Yousif NM, et al: Incidence of virulence factors and antibiotic resistance among Enterococci isolated from food. Appl Environ Microbiol 67(9):4385-4389, 2001.
29. Gionchetti P, Rizzello F, Venturi A, Campieri M: Probiotics in infective diarrhea and inflammatory bowel diseases. J Gastroenterol Hepatol 15(5):489-493, 2000.
30. Perdigon G, Alvarez S, Rachid M, et al: Immune system stimulation by probiotics. J Dairy Sci 78(7):1597-1606, 1995.
31. Kalliomaki M, Salminen S, Arvilommi H, et al: Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet 35(9262)7:1076-1079, 2001.
32. Schultz M, Sartor RB: Probiotics and inflammatory bowel diseases. Am J Gastroenterol 95(suppl 1):S19-S21, 2000.
33. Fox JG, Batchelder M, Marini R, et al: Helicobacter pylori-induced gastritis in the domestic cat. Infect Immun 63(7):2674-2681, 1995.
34. Peyrol S, Lecoindre P, Berger I, et al: Differential pathogenic effect of two Helicobacter-like organisms in dog gastric mucosa. J Submicrosc Cytol Pathol 30(3):425-433, 1998.
35. Midolo PD, Lambert JR, Hull R, et al: In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacterial 79(4):475-479, 1995.
36. Michetti P, Dorta G, Wiesel PH, et al: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) Lal on Helicobacter pylori infection in humans. Digestion 60(3):203-209, 1999.
37. Felley C, Blanco JL, Sipponen P, et al: Favourable effect of LC-1 yogurt on Helicobacter pylori gastritis in man. Gastroenterology 114:3240, 2000.
38. Buddington RK: Postnatal changes in bacterial populations in the gastrointestinal tract of dogs. Am J Vet Res 64(5):646-651, 2003.
39. Allaker RP, Jensen L, Lloyd DH, Lamport AI: Colonization of neonatal puppies by staphylococci. Br Vet J 148(6):523-528, 1992.
40. Audisio MC, Oliver G, Apella MC: Antagonistic effect of Enterococcus faecium J96 against human and poultry pathogenic Salmonella spp. J Food Prot 62(7):751-755, 1999.
41. Kraehenbuhl JP, Neutra MR: Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 72(4):853-879, 1992.
42. Pochapin M: The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 95 (suppl 1):S11-S13, 2000.
43. Donnet-Hughes A, Rochat F, Serrant P, et al: Modulation of nonspecific mechanisms of defense by lactic acid bacteria: Effective dose. J Dairy Sci 82(5):863-869, 1999.
44. Link-Amster H, Rochat F, Saudan KY, et al: Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10(1):55-63, 1994.
45. Carmichael LE, Binn LN: New enteric viruses in the dog. Adv Vet Sci Comp Med 25:1-37, 1981.
46. Benyacoub, et al: Unpublished data.
47. Saavedra JM, Bauman NA, Oung I, et al: Feeding of Bifidobacterium bi-fidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344(8929):104S-1049, 1994.
48. Quan CP, Berneman A, Pires R, et al: Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 65(10):3997-4004, 1997.
49. Kato H, Kato R, Fujihashi K, McGhee JR: Role of mucosal antibodies in viral infections. Curr Top Microbiol Immunol 260:201-228, 2001.
50. Benyacoub, et al: Manuscript in preparation.
51. Isolauri E, Arvola T, Sutas Y, et al: Probiotics in the management of atopic eczema. Clin Exp Allergy 30(11):1604-1610, 2000.
52. Gorenek L, Dizer U, Besirbellioglu B, et al: The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea. Hepatogastroenterology 46(25):343-348, 1999.
53. Wells CL, van de Westerlo EM, Jechorek RP, et al: Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial intemalization by HT-29 enterocytes. Gastroenterology 110(5): 1429-1437, 1996.
54. Biller JA, Katz AJ, Flores AF, et al: Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 21(2):224-226, 1995.
55. Rolfe RD, Helebian S, Finegold SM: Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis 143(3):470-475, 1981.
56. Swanson KS, Grieshop CM, Flickinger EA, et al: Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. J Nutr 132(12)3721-3731, 2002.